To include your compound in the COVID-19 Resource Center, submit it here.
Allergan plc (NYSE:AGN) will acquire Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) for $75 per share, or about $2.1 billion in cash and stock. The price represents
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury